Skip to main content

Peer Review reports

From: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China

Original Submission
12 Oct 2020 Submitted Original manuscript
10 Nov 2020 Reviewed Reviewer Report
11 Nov 2020 Reviewed Reviewer Report
15 Nov 2020 Reviewed Reviewer Report
23 Dec 2020 Author responded Author comments - Chathika Krishan Weerasuriya
Resubmission - Version 2
23 Dec 2020 Submitted Manuscript version 2
15 Jan 2021 Reviewed Reviewer Report
20 Jan 2021 Reviewed Reviewer Report
28 Jan 2021 Author responded Author comments - Chathika Krishan Weerasuriya
Resubmission - Version 3
28 Jan 2021 Submitted Manuscript version 3
Publishing
29 Jan 2021 Editorially accepted
26 Feb 2021 Article published 10.1186/s12916-021-01932-7

You can find further information about peer review here.

Back to article page